查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1427183

全球电生理设备市场规模、份额、成长分析、按应用、按适应症、按最终用途 - 2023-2030 年产业预测

Global Electrophysiology Devices Market Size, Share, Growth Analysis, By Application, By Indication(Atrial Fibrillation, Supraventricular Tachycardia), By End-Use - Industry Forecast 2023-2030
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球电生理设备市场规模为61亿美元，在预测期（2024-2031年）从2023年的67.8亿美元成长到2031年的158.1亿美元，预计复合年增长率为11.16 %。

除了越来越多地使用电生理学(EP) 测试来预防和治疗心房颤动等心臟病之外，对心律管理设备的需求也不断增长，尤其是在医院外进行持续监测。这就是推动这一趋势的原因行业的成长。据美国疾病管制与预防中心称，久坐的生活方式、吸烟和过量饮酒等因素导致千禧一代心臟衰竭、心臟心臟麻痹和心房颤动的发病率增加。据美国疾病控制和预防中心称，估计有1,210 万美国患有心臟衰竭、心臟衰竭和心房颤动。预计到 2030 年将出现心房颤动。此外，根据欧洲心臟学会的说法，心房颤动在欧洲裔美国人中比非裔美国人更常见，并且是西方国家心臟麻痹的主要原因。这就是导致这种疾病的原因，其发生率为1%。每年1,000人。由于心臟病患病率不断上升，电生理设备对于心律不整的检测和治疗至关重要，正在推动市场扩张。这些设备促进了行动心臟监测和动态心电图（ECG）跟踪，而植入式心臟设备的远端监测、云端资料储存和无线传输等进步进一步推动了市场成长。这些技术进步不仅使医疗保健提供者能够获得宝贵的患者信息，例如消融治疗的 3D 照片和视频，而且符合患者对微创治疗的偏好。冷冻消融、雷射治疗、超音波消融和增强测绘技术等新兴技术有望为该领域带来更多好处。值得注意的是，Medtronic力于2022年2月FDA核准Freezor ， Freezor强调了进步和创新。

自上而下和自下而上的方法已用于估计和检验全球电生理设备市场的规模，并估计其他各个相关子市场的规模。用于估计市场规模的调查方法包括以下详细资讯：用于确定市场主要企业的二次研究，用于确定每个地区的市场占有率的主要和二次研究。整个过程包括研究主要企业的年度和财务报告以及广泛的采访，以获得执行长、副总裁、董事和行销负责人等行业领导者的重要见解。所有股份比率和细分均使用二手资讯确定并使用主要资讯检验。本研究涵盖的所有可能影响市场的参数都经过详细考虑，并透过初步研究检验并进行分析，以获得最终的定量和定性资料。

全球电生理设备市场按细分市场分析

全球电生理设备市场根据应用、适应症、最终用途和地区进行细分。依用途分为治疗设备和诊断设备。根据适应症，市场分为心房颤动（AF）、室上性心搏过速、房室结折返性心动过速（AVNRT）、沃尔夫-巴金森-怀特氏症候群（WPW）、心搏过缓等。根据最终用途，市场分为医院、门诊手术中心等。按地区划分，全球电生理设备市场分为北美、欧洲、亚太地区、南美洲和中东和非洲。

电生理设备的全球市场驱动因素

心房颤动和心室心搏过速等心律不整的发生率不断增加，大大推动了对电生理设备的需求。这些疾病需要准确的诊断和治疗，而电生理设备非常适合促进这一点。

全球电生理设备市场的限制因素

然而，电生理设备的负担能力是一个挑战，可能会阻碍其广泛普及，特别是在医疗保健预算有限的地区或具有严格报销政策的医疗保健框架中。电生理测试设备的高成本可能会阻碍市场成长。

全球电生理设备市场趋势

在电生理学领域，微创技术正变得越来越流行。技术和导管设计的进步使得基于导管的手术更容易更精确地诊断和治疗心律不整，最大限度地减少患者的不适，缩短恢復时间，并且现在可以减少併发症的可能性。

目录

  • 执行摘要
  • 调查方法
  • 母市场分析
  • 主要市场考察
    • 技术分析
    • 价格分析
    • 供应链分析
    • 价值链分析
    • 市场生态系统
    • 智慧财产权分析
    • 贸易分析
    • Start-Ups分析
    • 原料分析
    • 创新矩阵
    • 研发线产品分析
    • 总体经济指标
    • 主要投资分析
    • 关键成功因素
    • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
    • 监管形势
    • 波特的分析
    • 对未来中断的特殊考虑
  • 全球电生理设备市场：依应用分类
    • 市场概况
    • 治疗设备
    • 诊断设备
  • 全球电生理设备市场：依适应症分类
    • 市场概况
    • 心房颤动（AF）
    • 心室上性心搏过速
    • 房室结折返性心搏过速(AVNRT)
    • 沃尔夫-巴金森-怀特氏症候群(WPW)
    • 心搏过缓
    • 其他的
  • 全球电生理设备市场：依最终用途分类
    • 市场概况
    • 医院
    • 门诊手术中心
    • 其他的
  • 全球电生理设备市场规模：依地区划分
    • 市场概况
    • 北美洲
      • 美国
      • 加拿大
    • 欧洲
      • 德国
      • 西班牙
      • 法国
      • 英国
      • 其他欧洲国家地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 拉丁美洲
      • 巴西
      • 其他拉丁美洲地区
    • 中东和非洲 (MEA)
      • 海湾合作委员会国家
      • 南非
      • 其他中东/非洲地区
  • 竞争形势
    • 前5名企业对比
    • 主要企业市场定位（2021年）
    • 主要市场参与者所采取的策略
    • 关键成功策略
    • 近期市集活动
    • 主要企业市场占有率（2021年）
  • 主要企业简介
    • Abbott Laboratories
    • Medtronic plc
    • Boston Scientific Corporation
    • Biosense Webster（a Johnson & Johnson company）
    • St. Jude Medical（part of Abbott Laboratories）
    • Siemens Healthineers
    • Koninklijke Philips NV
    • GE Healthcare
    • MicroPort Scientific Corporation
    • Biotronik SE & Co. KG
    • CardioFocus Inc.
    • LivaNova PLC
    • Penumbra, Inc.
    • Stereotaxis, Inc.
    • nContact, Inc.（part of AtriCure, Inc.）
    • Advanced Cardiac Therapeutics, Inc.
    • CathRx Ltd.
    • Osypka Medical GmbH
    • Auris Health, Inc.（part of Johnson & Johnson）
    • AngioDynamics, Inc.
简介目录
Product Code: SQMIG35A2420

Global Electrophysiology Devices Market size was valued at USD 6.10 billion in 2022 and is poised to grow from USD 6.78 billion in 2023 to USD 15.81 billion by 2031, growing at a CAGR of 11.16% during the forecast period (2024-2031).

The increasing utilization of electrophysiology (EP) tests for both preventing and treating heart diseases like atrial fibrillation, alongside a rising demand for cardiac rhythm management equipment for continuous monitoring, particularly in out-of-hospital settings, is propelling industry growth. Factors such as sedentary lifestyles, smoking, excessive alcohol consumption, among others, contribute to the rising incidence of heart failure, sudden cardiac arrest, and atrial fibrillation among millennials, with an estimated 12.1 million Americans projected to have AF by 2030, according to the Centers for Disease Control and Prevention. Moreover, atrial fibrillation affects Europeans more than African Americans, and it stands as a leading cause of sudden cardiac arrest in Western countries, affecting around one in every 1,000 individuals annually, as stated by the European Society of Cardiology. Electrophysiology devices, integral for detecting and managing heart arrhythmias, are driving market expansion due to the escalating prevalence of heart disease. These devices facilitate mobile cardiac monitoring and ambulatory electrocardiogram (ECG) tracking, while advancements like remote monitoring of implanted cardiac devices, data storage in the cloud, and wireless transmission further fuel market growth. This technological progress not only grants healthcare providers access to valuable patient information, including 3D photos and videos from ablation treatments but also aligns with patients' preference for minimally invasive procedures. Emerging techniques such as cryoablation, laser therapy, ultrasonic ablation, and enhanced mapping technologies promise additional benefits to the sector. Notably, Medtronic's FDA approval of the Freezor & Freezor Xtra Cardiac Cryoablation Focal Catheters in February 2022 for managing Atrioventricular Nodal Reentrant Tachycardia (AVNRT) in pediatric patients underscores the continued advancement and innovation in cardiac care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electrophysiology Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electrophysiology Devices Market Segmental Analysis

The global electrophysiology devices market is segmented on the basis of application, indication, end-use, and region. Based on application, the market is segmented into treatment devices, and diagnostic devices. Based on indication, the market is segmented into Atrial Fibrillation (AF), Supraventricular Tachycardia, Atrioventricular Nodal Re-entry Tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), Bradycardia, and other. Based on end-use the market is segmented into hospitals, ambulatory surgical centers, and others. Based on region the global Electrophysiology Devices Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Electrophysiology Devices Market

The increasing incidence of cardiac arrhythmias like atrial fibrillation and ventricular tachycardia significantly fuels the demand for electrophysiology devices. These conditions necessitate precise diagnosis and treatment, tasks that electrophysiology devices excel at facilitating.

Restraints in the Global Electrophysiology Devices Market

However, the affordability of electrophysiology devices presents a challenge, potentially hindering their widespread use, especially in areas with constrained healthcare budgets or within healthcare frameworks governed by stringent reimbursement policies. The substantial expenses associated with these devices can impede market growth.

Market Trends of the Global Electrophysiology Devices Market

Minimally invasive techniques are increasingly popular in the realm of electrophysiology. Progress in technology and catheter design has facilitated the creation of procedures that utilize catheters to diagnose and treat cardiac arrhythmias with enhanced precision, while also minimizing patient discomfort, shortening recovery periods, and reducing the likelihood of complications.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
    • Regulatory Landscape
    • Porters Analysis
      • Competitive rivalry
      • Threat of Substitute Products
      • Bargaining Power of Buyers
      • Threat of New Entrants
      • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
      • Political Impact
      • Economic Impact
      • Social Impact
      • Technical Impact
      • Environmental Impact
      • Legal Impact
  • Global Electrophysiology Devices Market by Application
    • Market Overview
    • Treatment Devices
    • and Diagnostic Devices
  • Global Electrophysiology Devices Market by Indication
    • Market Overview
    • Atrial Fibrillation (AF)
    • Supraventricular Tachycardia
    • Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
    • Wolff-Parkinson-White Syndrome (WPW)
    • Bradycardia
    • and Other
  • Global Electrophysiology Devices Market by End-Use
    • Market Overview
    • Hospitals
    • Ambulatory Surgical Centers
    • and Others
  • Global Electrophysiology Devices Market Size by Region
    • Market Overview
    • North America
      • USA
      • Canada
    • Europe
      • Germany
      • Spain
      • France
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC Countries
      • South Africa
      • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
      • By Development
      • By Company
      • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Abbott Laboratories
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Medtronic plc
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Boston Scientific Corporation
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Biosense Webster (a Johnson & Johnson company)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • St. Jude Medical (part of Abbott Laboratories)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Siemens Healthineers
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Koninklijke Philips N.V.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • GE Healthcare
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • MicroPort Scientific Corporation
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Biotronik SE & Co. KG
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • CardioFocus Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • LivaNova PLC
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Penumbra, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Stereotaxis, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • nContact, Inc. (part of AtriCure, Inc.)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Advanced Cardiac Therapeutics, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • CathRx Ltd.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Osypka Medical GmbH
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Auris Health, Inc. (part of Johnson & Johnson)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • AngioDynamics, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments